Cece Calhoun
MD, MPHS, MBA
Assistant Professor of Medicine (Hematology); Medical Director, Sickle Cell Program
Biography
Research & Publications
Patient Care
News
Locations
Appointments
Biography
Dr. Cecelia Calhoun, MD, MPHS, MBA, is an Assistant Professor of Medicine (Hematology) and (Hematology/Oncology) at Yale University School of Medicine, specializing in the care of individuals with Sickle Cell Disease (SCD). She also serves as the Medical Director of the Adult Sickle Cell Program at Smilow Cancer Hospital.
Dr. Calhoun's research focuses on addressing educational and healthcare obstacles faced by adolescents with sickle cell disease, employing mixed methods to find effective solutions. Her career is dedicated to designing and implementing evidence-based interventions that support a successful transition from youth to adult care for individuals with sickle cell disease. As an NIH-funded investigator, she collaborates with hematology colleagues nationwide, utilizing Implementation Science methods to improve outcomes for patients with sickle cell disease across their lifespan.
Dr. Calhoun's expertise and dedication make her a respected figure in the field of hematology, particularly in the realm of sickle cell disease and health equity. Her commitment to improving outcomes for individuals with sickle cell disease underscores her valuable contributions to the academic and medical community.
Education & Training
- MBAYale University, School of Management (2021)
- Saunders-Watkins Leadership WorkshopNational Institutes of Health (2018)
- Advocacy Leadership InstituteAmerican Society of Hematology (2018)
- Clinical Research Training InstituteAmerican Society of Hematology (2018)
- MPHSWashington University in St Louis, Population Health Science (2017)
- Clinical FellowWashington University School of Medicine (2017)
- Pediatric ResidentGrand Rapids Medical Education Partners-Michigan State University (2014)
- MDWayne State University, Medicine (2011)
- BAUniversity of Michigan, Afro American Studies (2006)
Activities
- Negotiation: It's More Than Just the MoneyNew Orleans, LA, United States 2022American Society of Hematologists Annual Meeting
- Training Program Director's Workshop: Diversity, Equity & InclusionNew Orleans, LA, United States 2022American Society of Hematology Annual Meeting
- Bridging the Gap: Using Implementation Science to Improve Transition in Sickle Cell DiseaseStamford, CT, United States 2022Pediatric Grand Rounds
- Moving Forward: The Transition From Pediatric to Adult Care in Sickle Cell DiseaseNew Haven, CT, United States 2022Yale Dean's Workshop: Innovations in Clinical Investigation at Yale
- sing CFIR and iPARIHS to Conduct Deductive Coding of Provider Interviews to Inform Implementation MappingPoster Session: Models, Measures, and Methods" at the Virtual D&I Conference, December 15-17, 2020. 2020Using CFIR and iPARIHS to Conduct Deductive Coding of Provider Interviews to Inform Implementation Mapping
- Leap of Faith: The Transition from Pediatric to Adult Care in Sickle Cell DiseaseSt. Louis, MO, United States 2020Leap of Faith: The Transition from Pediatric to Adult Care in Sickle Cell Disease
- Using Implementation Science to Improve Transition for Adolescents and Young Adults with Sickle Cell DiseaseWashington, DC, United States 2018Using Implementation Science to Improve Transition for Adolescents and Young Adults with Sickle Cell Disease
- Optimizing Care for Patients with Sickle Cell Disease: Understanding Barriers and FacilitatorsBethesda, MD, United States 2017Optimizing Care for Patients with Sickle Cell Disease: Understanding Barriers and Facilitators
- Current Healthcare Utilization Patterns and Most Common Reasons for Admission Amongst Patients with Sickle Cell DiseaseAtlanta, GA, United States 2017Current Healthcare Utilization Patterns and Most Common Reasons for Admission Amongst Patients with Sickle Cell Disease
- Higher prevalence of hydroxyurea use is associated with lower hospitalization rate in a population of children with sickle cell diseaseSan Diego, CA, United States 2016Higher prevalence of hydroxyurea use is associated with lower hospitalization rate in a population of children with sickle cell disease
- Implementation of an Educational Intervention to Optimize Self-Management and Transition Readiness in Adolescents with Sickle Cell DiseaseSan Diego, CA, United States 2016Implementation of an Educational Intervention to Optimize Self-Management and Transition Readiness in Adolescents with Sickle Cell Disease
Honors & Recognition
| Award | Awarding Organization | Date |
|---|---|---|
| Top health Professionals Under Forty | National Medical Association | 2022 |
| Guardian of Childhood | St Louis Children’s Hospital | 2021 |
| Dean's Mission & Impact Award | Yale School of Management | 2021 |
| Faculty Diversity Scholars Award | Washington University School of Medicine | 2021 |
| Loan Repayment Program in Pediatric Research | National Institutes of Health | 2019 |
| Pozen-Commonwealth Fund Fellowship in Minority Health Leadership | Commonwealth Fund-Yale University School of Management | 2019 |
| American Society of Hematology Clinical Research Training Institute | American Society of Hematology | 2017 |
| Genevieve Hitchman Memorial Scholarship | Wayne State University School of Medicine | 2006 |
| Minority Health International Research Training Fogarty Fellowship | National Institutes of Health | 2005 |
| Delta Epsilon Iota National Honors Fraternity | University of Michigan | 2002 |
Professional Service
| Organization | Role | Date |
|---|---|---|
| NIH Special Emphasis panel on HEAL: Advancing Equity in Pain and Comorbidities | Reviewer | 2022 |
| Schwartz Rounds Planning Committee | Member | 2022 - Present |
| Yale Cancer Center Health Care Delivery Search Committee | Member | 2022 - Present |
| American Academy of Pediatrics | Fellow | 2022 - Present |
| Pediatric Blood and Cancer | Reviewer | 2022 - Present |
| Health and Veritas Podcast | Expert | 2022 - Present |
| Blood Advances | Reviewer | 2021 - Present |
| Gastrointestinal Medical Oncology Search Committee | Member | 2021 - Present |
| Sickle Cell Disease Association of America- Southern Connecticut Chapter, Sickle Cell Disease Association of America- Southern Connecticut Chapter | Advisor | 2021 - Present |
| Yale Cancer Answers Radio Show | Expert | 2021 - Present |
| Washington Post Live: Health care Resilience and Sustainability | Expert | 2021 - Present |
| National Medical Association | Member | 2020 - Present |
| JAMA Network Open | Reviewer | 2020 - Present |
| Neuro-Heme Consortium 2 (NHC2) Study DSMB | Co-Chair | 2019 - Present |
| American Society of Hematology | Abstract Reviewer | 2019 - Present |
| Journal of Clinical Medicine | Reviewer | 2019 - Present |
| American Society of Hematology Clinical Research Training Institute Steering Subcommittee | Committee Member | 2018 - 2021 |
| Sickle Cell Quality and Operations Committee, Barnes Jewish Hospital | Member | 2018 - 2021 |
| Inhaled Mometasone to Promote Reduction in Vaso-occlusive Events 2 (IMPROVE2) Study DSMB | Committee Member | 2018 - Present |
| Community Sickle Cell Initiative | Committee Member | 2018 - 2020 |
| Sickle Cell Disease Implementation Consortium-Needs Assessment Subcommittee, NIH NHLBI | Co-Chair | 2016 - 2017 |
Departments & Organizations
- Cancer Prevention and Control
- Hematology
- Internal Medicine
- Janeway Society
- Pediatric Hematology & Oncology
- Pediatric Hematology & Oncology Program
- Sickle Cell Program at Smilow Cancer Hospital
- Yale Cancer Center
- Yale Medicine